StockData
Sinovac Biotech Ltd logo

Sinovac Biotech Ltd (SVA) income statement

SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 5, 2026Score 7/30
$6.47+0.00 (0.00%)

Close on Nov 20, 2026Market cap $464.94MP/E –Yield 850.08%

See a number that looks wrong?